Structural Changes in a Viral Glycoprotein Epitopes Is Differentially Influenced by the -Restricted d Antigen Processing of Two H2-IE

[1]  J. Haefliger,et al.  The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. , 1997, Journal of immunology.

[2]  G. Hämmerling,et al.  HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.

[3]  C. Harding,et al.  Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. , 1997, Journal of immunology.

[4]  R. Germain,et al.  Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein , 1997, The Journal of experimental medicine.

[5]  J. Blum,et al.  Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. , 1997, Journal of immunology.

[6]  S. Pierce,et al.  HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. , 1996, Journal of immunology.

[7]  E. Unanue,et al.  Distinct antigen MHC class II complexes generated by separate processing pathways. , 1996, The EMBO journal.

[8]  P. Cresswell,et al.  HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.

[9]  A. Sant,et al.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.

[10]  P. Chavrier,et al.  Characterization of a Lysozyme-Major Histocompatibility Complex Class II Molecule-loading Compartment as a Specialized Recycling Endosome in Murine B Lymphocytes* , 1996, The Journal of Biological Chemistry.

[11]  R. Germain,et al.  Processing and Presentation of Endocytically Acquired Protein Antigens by MHC Class II and Class I Molecules , 1996, Immunological reviews.

[12]  P. Cresswell,et al.  HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. , 1996, Immunity.

[13]  V. Engelhard,et al.  Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. , 1996, Journal of immunology.

[14]  G. Hämmerling,et al.  Self-Release of CLIP in Peptide Loading of HLA-DR Molecules , 1995, Science.

[15]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[16]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[17]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[18]  Eric O Long,et al.  Antigen presentation mediated by recycling of surface HLA-DR molecules , 1995, Nature.

[19]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[20]  J. Trowsdale,et al.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.

[21]  P. Cresswell,et al.  In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. , 1994, Immunity.

[22]  A. Rudensky,et al.  Intracellular assembly and transport of endogenous peptide-MHC class II complexes. , 1994, Immunity.

[23]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[24]  Eric O Long,et al.  Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. , 1994, Journal of immunology.

[25]  H. Ploegh,et al.  Isolation and characterization of the intracellular MHC class II compartment , 1994, Nature.

[26]  I. Mellman,et al.  Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes , 1994, Nature.

[27]  C. Watts,et al.  Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells , 1994, Nature.

[28]  A. Wandinger-Ness,et al.  Separation of subcellular compartments containing distinct functional forms of MHC class II , 1994, The Journal of cell biology.

[29]  M. Taylor,et al.  Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[31]  Eric O Long,et al.  Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Rock,et al.  A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. , 1993, Journal of immunology.

[33]  J. Yewdell,et al.  Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments , 1993, The Journal of experimental medicine.

[34]  J. Yewdell,et al.  Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region , 1993, Journal of virology.

[35]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[36]  J. Yewdell,et al.  Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes , 1992, Cell.

[37]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[38]  P. Cresswell.  Chemistry and functional role of the invariant chain , 1992, Current Biology.

[39]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[40]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[41]  J. Yewdell,et al.  Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Yewdell,et al.  Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation. , 1991, Journal of immunology.

[43]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[44]  A. Taylor,et al.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.

[45]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[46]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[47]  P. Cresswell,et al.  Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment , 1990, Nature.

[48]  L. Eisenlohr,et al.  Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis , 1989, The Journal of experimental medicine.

[49]  L. Eisenlohr,et al.  Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells. , 1988, Journal of immunology.

[50]  L. Eisenlohr,et al.  Acid-induced conformational modification of the hemagglutinin molecule alters interaction of influenza virus with antigen-presenting cells. , 1988, Journal of immunology.

[51]  P. Cresswell,et al.  Role for intracellular proteases in the processing and transport of class II HLA antigens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Scherle,et al.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  I. Wilson,et al.  Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin , 1987, The Journal of cell biology.

[54]  R. Doms,et al.  Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. , 1985, The Journal of biological chemistry.

[55]  W. Gerhard,et al.  Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities. , 1984, Journal of immunology.

[56]  F. Melchers,et al.  The recognition specificity of a murine helper T cell for hemagglutinin of influenza virus A/PR/8/34. , 1983, Journal of immunology.

[57]  J. Yewdell,et al.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) , 1982, Cell.

[58]  I. Wilson,et al.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[59]  A Helenius,et al.  Infectious entry pathway of influenza virus in a canine kidney cell line , 1981, The Journal of cell biology.

[60]  R. Webster,et al.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies , 1981, Nature.

[61]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[62]  D H Sachs,et al.  Establishment and characterization of BALB/c lymphoma lines with B cell properties. , 1979, Journal of immunology.

[63]  H. Klenk,et al.  Activation of influenza A viruses by trypsin treatment. , 1975, Virology.

[64]  P. Choppin,et al.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.

[65]  J. Skehel,et al.  Crystalline antigen from the influenza virus envelope. , 1972, Nature: New biology.

[66]  R. Germain,et al.  Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. , 1995, Immunity.

[67]  J. Skehel,et al.  Membrane fusion by influenza hemagglutinin. , 1995, Cold Spring Harbor symposia on quantitative biology.

[68]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[69]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[70]  J. Skehel,et al.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. , 1987, Annual review of biochemistry.

[71]  E. Unanue.  Antigen-presenting function of the macrophage. , 1984, Annual review of immunology.